Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103749 · ClinicalTrials.gov registry record · NA
Global Prospective Case Series Using a Single-Use Duodenoscope
A NA study of Endoscopic Retrograde Cholangiopancreatography, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 551
- Enrollment target
- 20
- Study locations
NCT04103749 is a NA study of Endoscopic Retrograde Cholangiopancreatography that has completed, run by Boston Scientific Corporation. The registered enrollment target is 551 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT04103749, a NA study of Endoscopic Retrograde Cholangiopancreatography, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 551 participants
- Enrollment target
- 20
- Study locations
Study Summary
Confirm procedural performance of the ExaltTM Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures
Conditions Studied
Interventions
- DEVICE Exalt Model D Single-Use Duodenoscope
Study Locations (20)
Other
- Metro North Hospital and Health Services - Brisbane
- St. Michael's Hospital - Unity Health - Toronto
- Institut Paoli-Calmettes - Marseille
- Prince of Wales Hospital - Hong Kong
- Humanitas University - Milan
- Erasmus University Medical Center of Rotterdam - Rotterdam
New York
- North Shore University Hospital - Manhasset
- Cornell Medical Center - New York
California
- University of California Los Angeles Medical Center - Los Angeles
Illinois
- University of Chicago - Chicago
Indiana
- Indianapolis University Hospital - Indianapolis
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2023-01-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04103749
The ClinicalTrials.gov registry entry for NCT04103749 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endoscopic Retrograde Cholangiopancreatography appearing as the primary indexed condition, and to 1 intervention - of which Exalt Model D Single-Use Duodenoscope is the first listed.
NCT04103749 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, New York, California.
Frequently Asked Questions
What is clinical trial NCT04103749 about?
NCT04103749 is a clinical study titled "Global Prospective Case Series Using a Single-Use Duodenoscope". Confirm procedural performance of the ExaltTM Model D Single-Use Duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and other duodenoscope-based procedures
What is the current status of trial NCT04103749?
This trial is currently completed. It is a NA study. The enrollment target is 551 participants. The study started on 2021-03-22. Estimated completion is 2023-01-05.
What conditions does trial NCT04103749 study?
This clinical trial studies the following conditions: Endoscopic Retrograde Cholangiopancreatography.
What interventions are being tested in trial NCT04103749?
The interventions under investigation include: Exalt Model D Single-Use Duodenoscope (DEVICE).
Who is sponsoring clinical trial NCT04103749?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04103749 being conducted?
This trial has 20 study locations across California, Illinois, Indiana, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopic Retrograde Cholangiopancreatography
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.